Ligand validation:4WSU

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4WSU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4WSU_NAG_E_402	47%	16%	0.167	0.906	0.83	2.8	-	8	0	0	100%	0.9333
4WSU_NAG_A_403	38%	37%	0.191	0.894	0.6	1.82	-	1	0	0	100%	0.9333
4WSU_NAG_C_403	34%	18%	0.172	0.853	0.74	2.74	-	7	0	0	100%	0.9333
4WSU_NAG_A_402	32%	77%	0.187	0.861	0.29	0.62	-	-	1	1	100%	0.9333
4WSU_NAG_C_402	24%	77%	0.175	0.802	0.28	0.62	-	-	0	0	100%	0.9333
4WSU_NAG_C_401	24%	27%	0.212	0.839	0.48	2.43	-	2	0	0	100%	0.9333
4WSU_NAG_E_400	13%	34%	0.22	0.762	0.68	1.89	-	7	0	0	100%	0.9333
4WSU_NAG_A_401	7%	77%	0.274	0.735	0.29	0.61	-	-	0	0	100%	0.9333
4WSU_NAG_E_401	5%	78%	0.251	0.656	0.28	0.61	-	-	0	0	100%	0.9333
5BR3_NAG_C_403	100%	46%	0.042	0.982	0.77	1.32	1	1	0	0	100%	0.9333
5BR6_NAG_C_402	99%	63%	0.046	0.984	0.7	0.73	1	1	1	0	100%	0.9333
5BR0_NAG_C_403	99%	78%	0.049	0.98	0.24	0.65	-	1	0	0	100%	0.9333
4YY7_NAG_D_501	96%	17%	0.062	0.973	1.99	1.61	1	1	3	0	100%	0.9333
4YY1_NAG_B_501	91%	47%	0.076	0.962	0.49	1.51	-	2	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.